Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Role: Associate - Policy Engagement Experience: 4+ years Salary: Upto 15 LPA _ Role Overview We seek individuals to work in our Policy Engagement vertical and help us in the creation of evidence-backed collaterals. This will